Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GUFICBIO | NSE
10.10
2.68%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
09/06/2026
386.80
379.00
392.95
377.80
Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs) generic pharmaceuticals and related services in India. It manufactures APIs and bulk drugs such as antifungals anesthetics immuno suppressants and intermediates for antifungals. The company also manufactures lyophilized injections which include antibiotic antifungal cardiac infertility antiviral and proton-pump inhibitor segments. In addition it offers spark criti care and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai India.
View LessPositive Momentum
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
35.9%1 month
49.3%3 months
42.5%6 months
36.5%50.00
-
7.99
0.63
0.30
31.17
5.96
-
1.47B
38.80B
406.98M
0.02
15.52
-2.30
4.00
19.57
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
83.70
Range1M
125.65
Range3M
125.80
Rel. volume
0.71
Price X volume
47.62M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 607.75 | 37.94B | 9.92% | n/a | 2.49% |
| RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 2117.1 | 35.03B | 1.35% | 50.00 | 0.00% |
| Aarti Drugs Limited | AARTIDRUGS | Drug Manufacturers-Specialty & Generic | 376.1 | 34.37B | 2.75% | 27.18 | 44.03% |
| ZOTA | ZOTA | Biotechnology | 1211.2 | 31.40B | 0.59% | n/a | 105.90% |
| Dishman Carbogen Amcis Limited | DCAL | Biotechnology | 187.92 | 29.46B | 1.93% | n/a | 41.09% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 48.65 | 26.87B | 13.48% | 37.53 | 3.42% |
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 379.65 | 26.83B | 6.37% | n/a | 10.48% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 580 | 25.13B | 10.50% | n/a | 107.90% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 181.32 | 22.36B | 0.86% | 69.03 | 68.84% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 86.73 | 22.35B | 1.17% | 12.29 | 0.42% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 42.68 | 37.44B | 4.99% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 108.82 | 16.03B | 4.71% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 270.05 | 15.83B | 3.79% | 30.54 | 80.30% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 307.8 | 9.94B | 5.00% | 36.36 | 52.08% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 238.89 | 8.52B | 0.82% | 120.49 | 191.28% |
| Madhav Copper Limited | MCL | Copper | 59.07 | 1.63B | 0.14% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 85.57 | 1.24B | -0.62% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 69.98 | 780.19M | -0.03% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 25.26 | 438.51M | 1.12% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.19 | 157.53M | 1.84% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 31.17 | 24.85 | Expensive |
| Ent. to Revenue | 5.96 | 11.40 | Cheaper |
| PE Ratio | 50.00 | 51.36 | Par |
| Price to Book | 7.99 | 6.83 | Par |
| Dividend Yield | 0.02 | 0.52 | Poor |
| Std. Deviation (3M) | 42.51 | 42.17 | Par |
| Debt to Equity | 0.63 | 0.35 | Expensive |
| Debt to Assets | 0.30 | 0.17 | Expensive |
| Market Cap | 38.80B | 290.82B | Emerging |